DrStore turns 10: From India's first healthcare GPO to a MedTech innovator shaping the future of metabolic health

DrStore turns 10: From India's first healthcare GPO to a MedTech innovator shaping the future of metabolic health

author-image
manoj sharma
New Update
DrStore turns 10: From India’s first healthcare GPO to a MedTech innovator shaping the future of metabolic health

(source : ANI) ( Photo Credit : ani)

VMPL

New Delhi [India], August 8: DrStore, a homegrown healthtech company, marks its 10th anniversary today with a bold new focus on technology-driven innovation in chronic and metabolic health management.

Founded in 2015 as India first healthcare Group Purchasing Organization (GPO), DrStore began with a mission to streamline medical procurement and healthcare delivery across institutions. Over the past decade, the company has evolved from being a B2B supply chain player to becoming a trusted partner in real-time and continuous vital monitoring using smart medical devices.

The last 10 years have been about building the foundation -- navigating operational challenges, serving frontline care teams, and understanding India healthcare delivery gaps from the ground up, said Neeraj Katare, CEO and co-founder of DrStore. Were proud of what weve built, but the real journey -- the innovation-led one -- begins now.

DrStore position as a medtech innovator was carved in stone with the launch of Tracky CGM -- India first Bluetooth-enabled continuous glucose monitor. The product marked a major inflection point, not only for the company but also for India digital health ecosystem, offering real-time metabolic insights to both consumers and clinicians.

At the core of this vision is the company ambition to build devices and technologies that offer real-time insights into metabolic and cardiac health -- powered with AI to deliver connected intelligence and empower caregivers to make informed treatment decisions.

We are building a tech-first healthcare company -- not just connected devices, but intelligent infrastructure, said Katare. Our R&D is focused on integrating AI models that can detect trends, predict deterioration, and support clinical decisions, all in real time. The future of care isnt episodic -- it continuous, data-led, and hyper-personalized. That what were engineering.

DrStore has built a connected ecosystem of smart home monitoring devices and professional diagnostic tools -- including ambulatory blood pressure monitors for cardiovascular care -- deployed across millions of homes through partners such as corporates, wellness programs, and caregiving platforms.

This is powered by an AI-enabled tech layer that allows doctors to access and interpret real-time vitals remotely, transforming raw data into clinical insights. Currently active in 25,000+ pincodes, DrStore is now looking to take its indigenous technologies global, with partnerships across North America, Southeast Asia, and other emerging markets.

The timing of this innovation push is critical. India is witnessing an unprecedented rise in lifestyle-related diseases -- with an estimated 1 in 4 adults living with hypertension and nearly 1 in 10 with diabetes, a large percentage of which remain undiagnosed. DrStore believes solving this public health challenge demands a new care model -- proactive, real-time, and tech-enabled.

This isnt just an anniversary -- it an inflection point, Katare said. Weve been a company of many firsts. From India first GPO to launching India first CGM -- and now, to building India first multi-biomarker patch -- were driven by the belief that Indian healthcare needs more than access. It needs intelligence, precision, and innovation at scale.

As DrStore steps into its second decade, it is setting its sights beyond borders. The company is now focused on building affordable, indigenous medtech solutions for cardio-metabolic care that are not only tailored for India, but designed to make a global impact -- especially in underserved and emerging markets.

Were innovating for India and beyond said Katare. Our mission is to build technically advanced, clinically meaningful devices here in India, and take them to global markets that need affordable, intelligent solutions for chronic care.

(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is solely responsible for its content.

Business Advertorial Disclaimer VMPL emerging markets Group Purchasing Organization